Related Experiment Video
Updated: Nov 2, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Non-cardiovascular comorbidities in heart failure patients and their impact on prognosis
Michele Correale1, Stefania Paolillo2,3, Valentina Mercurio4
1Department of Cardiology, University Hospital Foggia, Foggia, Italy. opsfco@tin.it.
Insights
Managing chronic heart failure (HF) requires addressing non-cardiovascular comorbidities. These conditions significantly impact patient prognosis, increasing hospitalizations and mortality rates, necessitating broader clinical expertise.
Area of Science:
- Cardiology
- Internal Medicine
- Geriatrics
Background:
- Aging populations and improved life expectancy increase the prevalence of chronic heart failure (HF).
- Patients with HF increasingly present with multiple cardiovascular (CV) and non-CV comorbidities.
- These comorbidities negatively impact HF prognosis, leading to higher hospitalization and mortality rates.
Purpose of the Study:
- To review novel aspects of non-CV comorbidities in HF patients.
- To emphasize the impact of non-CV comorbidities on HF prognosis.
- To highlight the need for comprehensive management strategies in HF.
Main Methods:
- Review of recent multicenter randomized studies.
- Analysis of data on pharmacological targets for comorbidities in HF.
- Discussion of clinical implications for HF management.
Main Results:
- Non-CV comorbidities are a significant challenge in HF management.
- Conditions like diabetes mellitus and iron deficiency are emerging as key targets.
- Effective HF care necessitates a broad understanding of associated non-CV conditions.
Conclusions:
- Non-CV comorbidities are critical determinants of prognosis in HF patients.
- Integrated management approaches considering all comorbidities are essential.
- Cardiologists require expanded expertise to address the complex needs of modern HF patients.
Abstract:
With the aging of the population and improvement of life expectancy of patients with heart disease, there is an increase in non-cardiovascular (CV) comorbidities affecting chronic heart failure (HF) patients. The increased prevalence of different CV and non-CV comorbidities is a rising problem in the management of patients with HF, mostly because these comorbidities may lead to poor prognosis, increase of hospitalizations and mortality rate. Recently, important data from multicenter randomized studies point to diabetes mellitus or iron deficiency as new pharmacological targets, and this highlights the need of broad expertise for the 21st-century cardiologist. The management of HF should take into account non-CV comorbidities. In this review, we discuss novel aspects of non-CV comorbidities in HF patients and emphasize the impact on prognosis.
More Related Videos
Related Concept Videos
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Heart Failure VII: Nursing Interventions
Heart Failure IV: Classification and Diagnostic Evaluation
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure III: Clinical Manifestations

